Literature DB >> 33317726

Linear accelerator stereotactic radiosurgery can modulate the clinical course of Hemangioblastoma: Case series and review of the literature.

Z Zibly1, Z R Cohen2, A Peled2, L Zach3, U Nissim2, Moshe Attia4, Christian Graves5, K Camphausen6, R Spiegelman2.   

Abstract

Hemangioblastomas (HB) are benign low grade vascular tumors most frequently occurring in the cerebellum, brain stem, and spinal cord. Often associated with Von Hippel Lindau disease (VHL), the lesions are often multifocal requiring complex resection and are difficult to control. Linear Accelerator (LINAC) Stereotactic Radiosurgery (SRS) has been demonstrated to provide additional tumor control. In this case series, we present our multi-center experience utilizing LINAC SRS in fourteen patients with 23 lesions. We observed a tumor control rate of 87% and found interval changes in the peritumoral enhancement to correlate with treatment outcome. In our study, SRS treatment was also well-tolerated in both cystic and noncystic patients with multifocal disease. Disease control was achieved in all but three patients post-resection and no longitudinal radiation-induced secondary malignancy was observed. SRS response correlated highly with lesion size and radiation dose. We conclude that LINAC SRS is safe and effective for patients with HB and should be considered in addition to surgery in asymptomatic, VHL patients, deep seated lesions and isolated lesions.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Hemangioblastoma; Radiosurgery; Von Hippel Lindau

Mesh:

Year:  2020        PMID: 33317726      PMCID: PMC8087173          DOI: 10.1016/j.jocn.2020.09.026

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  15 in total

1.  Radiosurgery for hemangioblastoma: results of a multiinstitutional experience.

Authors:  S J Patrice; P K Sneed; J C Flickinger; D C Shrieve; B E Pollock; E Alexander; D A Larson; D S Kondziolka; P H Gutin; W M Wara; M W McDermott; L D Lunsford; J S Loeffler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-06-01       Impact factor: 7.038

2.  Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment.

Authors:  Joshua M Ammerman; Russell R Lonser; James Dambrosia; John A Butman; Edward H Oldfield
Journal:  J Neurosurg       Date:  2006-08       Impact factor: 5.115

Review 3.  Gamma knife surgery for hemangioblastomas.

Authors:  Masao Tago; Atsuro Terahara; Masahiro Shin; Keisuke Maruyama; Hiroki Kurita; Keiichi Nakagawa; Kuni Ohtomo
Journal:  J Neurosurg       Date:  2005-01       Impact factor: 5.115

4.  Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study.

Authors:  Amparo Wolf; Kyla Naylor; Moses Tam; Akram Habibi; Josef Novotny; Roman Liščák; Nuria Martinez-Moreno; Roberto Martinez-Alvarez; Nathaniel Sisterson; John G Golfinos; Joshua Silverman; Hideyuki Kano; Jason Sheehan; L Dade Lunsford; Douglas Kondziolka
Journal:  Lancet Oncol       Date:  2018-11-22       Impact factor: 41.316

5.  Stereotactic radiosurgery for hemangioblastomas of the brain.

Authors:  A Jawahar; D Kondziolka; Y I Garces; J C Flickinger; B E Pollock; L D Lunsford
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

6.  Radiotherapeutic considerations in the treatment of hemangioblastomas of the central nervous system.

Authors:  S R Smalley; P J Schomberg; J D Earle; E R Laws; B W Scheithauer; J R O'Fallon
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-05       Impact factor: 7.038

7.  Cerebellar hemangioblastomas.

Authors:  D I Sung; C H Chang; L Harisiadis
Journal:  Cancer       Date:  1982-02-01       Impact factor: 6.860

Review 8.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

9.  Role of fractionated external beam radiotherapy in hemangioblastoma of the central nervous system.

Authors:  Eng-Siew Koh; Alan Nichol; Barbara-Ann Millar; Cynthia Ménard; Gregory Pond; Normand J Laperriere
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-14       Impact factor: 7.038

10.  The clinical outcome of intracranial hemangioblastomas treated with linac-based stereotactic radiosurgery and radiotherapy.

Authors:  Putipun Puataweepong; Mantana Dhanachai; Ake Hansasuta; Somjai Dangprasert; Chomporn Sitathanee; Parmon Puddhikarant; Chuleeporn Jiarpinitnun; Rawee Ruangkanchanasetr; Patchareporn Dechsupa; Kumutinee Pairat
Journal:  J Radiat Res       Date:  2014-02-18       Impact factor: 2.724

View more
  1 in total

Review 1.  Central Nervous System Hemangioblastoma in a Pediatric Patient Associated With Von Hippel-Lindau Disease: A Case Report and Literature Review.

Authors:  Bo Yang; Zhenyu Li; Yubo Wang; Chaoling Zhang; Zhen Zhang; Xianfeng Zhang
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.